Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [405]

Towards delivering truly personalised therapy for oesophageal cancer

Prof Tim Underwood - University of Southampton, Southampton, UK

Towards delivering truly personalised therapy for oesophageal cancer ( Prof Tim Underwood - University of Southampton, Southampton, UK )

PDL-1 assay concordance

Dr Jill Walker - AstraZeneca, UK

PDL-1 assay concordance ( Dr Jill Walker - AstraZeneca, UK )

ESMO 2016 conference highlights

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

ESMO 2016 conference highlights ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )

Results of the Activ8 trial of novel immunotherapy motolimod

Dr Ezra Cohen - UC San Diego, San Diego, USA

Results of the Activ8 trial of novel immunotherapy motolimod ( Dr Ezra Cohen - UC San Diego, San Diego, USA )

Highlights of ESMO 2016

Dr Andrés Cervantes - ESMO 2016 Scientific Chair

Highlights of ESMO 2016 ( Dr Andrés Cervantes - ESMO 2016 Scientific Chair )

Clinical trials investigating proton therapy for other indications

Prof Nancy Mendenhall - University of Florida, Gainesville, USA

Clinical trials investigating proton therapy for other indications ( Prof Nancy Mendenhall - University of Florida, Gainesville, USA )

Summary of developments in oesophageal and gastric cancers

Dr Caio Max Rocha Lima - Gibbs Cancer Center & Research Institute, Spartanburg...

Summary of developments in oesophageal and gastric cancers ( Dr Caio Max Rocha Lima - Gibbs Cancer Center & Research Institute, Spartanburg, South Carolina, USA )

ß1 integrins and DNA repair for radiosensitization of head and neck cancer

Dr Nils Cordes - Center for Radiation Research in Oncology, Dresden, Germany

ß1 integrins and DNA repair for radiosensitization of head and neck cancer ( Dr Nils Cordes - Center for Radiation Research in Oncology, Dresden, Germany )

'Rewiring' tumour susceptibility

Dr Michael Yaffe - MIT, Cambridge, USA

'Rewiring' tumour susceptibility ( Dr Michael Yaffe - MIT, Cambridge, USA )

A global perspective on infections related to cancer

Dr Silvia Franceschi - IARC, Lyon, France

A global perspective on infections related to cancer ( Dr Silvia Franceschi - IARC, Lyon, France )

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC

Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC ( Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA )

Cochlear sparing via intensity modulated radiotherapy

Dr Chris Nutting - Royal Marsden Hospital, London, UK

Cochlear sparing via intensity modulated radiotherapy ( Dr Chris Nutting - Royal Marsden Hospital, London, UK )

More from ecancer